Safe and Explainable AI

Not yet recruitingOBSERVATIONAL

Enrollment

300,000

Participants

Timeline

Start Date

November 29, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions

Artifical InteligenceCardiologyBreast CancerSepsis

Interventions

OTHER

AI-PERSONALIZED CLINICAL DECISION SUPPORT

AI-ENABLED DECISION MAKING FOR PERSONALIZED CLINICAL DECISION SUPPORT

All Listed Sponsors

lead

Abramson Cancer Center at Penn Medicine

OTHER